{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T19:40:04Z","timestamp":1747338004395,"version":"3.40.5"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca PLC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.rmed.2025.108107","type":"journal-article","created":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T22:56:47Z","timestamp":1745017007000},"page":"108107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Exploring a novel approach to COPD treatment: benralizumab effect in an ex vivo 3-D model"],"prefix":"10.1016","volume":"242","author":[{"given":"Alida","family":"Benfante","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8508-7728","authenticated-orcid":false,"given":"Alessandra","family":"Tomasello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Pitruzzella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8958-525X","authenticated-orcid":false,"given":"Alberto","family":"Fucarino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Marchese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Bucchieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6400-6573","authenticated-orcid":false,"given":"Nicola","family":"Scichilone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2025.108107_bib1","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2303951","article-title":"Dupilumab for COPD with type 2 inflammation indicated by eosinophil counts","volume":"389","author":"Bhatt","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.rmed.2025.108107_bib2","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1136\/thx.2004.024463","article-title":"Inflammatory cells in the airways in COPD","volume":"61","author":"O'Donnell","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2025.108107_bib3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.pupt.2016.03.004","article-title":"Blood eosinophils and treatment response in hospitalized exacerbations of chronic obstructive pulmonary disease: a case-control study","volume":"37","author":"Serafino-Agrusa","year":"2016","journal-title":"Pulm. Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.rmed.2025.108107_bib4","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01219-2018","article-title":"Inhaled corticosteroids in COPD: friend or foe?","volume":"52","author":"Agusti","year":"2018","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2025.108107_bib5","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S2213-2600(18)30006-7","article-title":"Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials","volume":"6","author":"Bafadhel","year":"2018","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.rmed.2025.108107_bib6","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1056\/NEJMoa1905248","article-title":"Benralizumab for the prevention of COPD exacerbations","volume":"381","author":"Criner","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rmed.2025.108107_bib7","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S2213-2600(19)30338-8","article-title":"Predicting response to benralizumab in chronic obstructive pulmonary disease: analyses of GALATHEA and TERRANOVA studies","volume":"8","author":"Criner","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.rmed.2025.108107_bib8","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1080\/01902148.2017.1303098","article-title":"Functional characterization of a novel 3D model of the epithelial-mesenchymal trophic unit","volume":"43","author":"Bucchieri","year":"2017","journal-title":"Exp. Lung Res."},{"key":"10.1016\/j.rmed.2025.108107_bib9","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1056\/NEJMe2305752","article-title":"Biologics for COPD \u2014 finally here","volume":"389","author":"Agusti","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rmed.2025.108107_bib10","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/j.jaci.2018.04.010","article-title":"Blood eosinophil count thresholds and exacerbations in patients with chronic obstructive pulmonary disease","volume":"141","author":"Yun","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2025.108107_bib11","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1183\/23120541.00437-2020","article-title":"Targeted therapy in eosinophilic chronic obstructive pulmonary disease","volume":"7","author":"Fieldes","year":"2021","journal-title":"ERJ Open Res."},{"issue":"1","key":"10.1016\/j.rmed.2025.108107_bib12","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1080\/02770903.2024.2388781","article-title":"A novel approach to investigate severe asthma and COPD: the 3d ex vivo respiratory mucosa model","volume":"62","author":"Fucarino","year":"2024","journal-title":"J. Asthma"},{"key":"10.1016\/j.rmed.2025.108107_bib13","article-title":"Endothelial dysfunction in chronic obstructive pulmonary disease: an update on mechanisms, assessment tools and treatment strategies","volume":"12","author":"Marcuccio","year":"2025","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.rmed.2025.108107_bib14","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.2147\/COPD.S155306","volume":"14","author":"Narendra","year":"2019","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"10.1016\/j.rmed.2025.108107_bib15","unstructured":"The RESOLUTE (Efficacy and safety of benralizumab in moderate to very severe chronic obstructive pulmonary disease (COPD) with a history of frequent exacerbations) trial (NCT04053634). https:\/\/clinicaltrials.gov\/study\/NCT04053634."},{"key":"10.1016\/j.rmed.2025.108107_bib16","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.2147\/COPD.S332505","article-title":"Interleukin-6 is a strong predictor of the frequency of COPD exacerbation within 1 year","volume":"16","author":"Huang","year":"2021","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"issue":"4","key":"10.1016\/j.rmed.2025.108107_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150586","article-title":"Inflammatory markers and the risk of chronic obstructive pulmonary disease: a systematic review and meta-analysis","volume":"11","author":"Su","year":"2016","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.rmed.2025.108107_bib18","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1111\/j.1365-2362.2012.02672.x","volume":"42","author":"Zdrenghea","year":"2012","journal-title":"Eur. J. Clin. Invest."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611125001696?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611125001696?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T19:22:16Z","timestamp":1747336936000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611125001696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":18,"alternative-id":["S0954611125001696"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2025.108107","relation":{},"ISSN":["0954-6111"],"issn-type":[{"type":"print","value":"0954-6111"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring a novel approach to COPD treatment: benralizumab effect in an ex vivo 3-D model","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2025.108107","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108107"}}